'ED should be afraid of God for lying so much; AAP to hold protests in Delhi: Party leaders
Biomm focuses on developing, manufacturing and commercialising complex biotech and biosimilar drug products at its production facility in Nova Lima
Covid-19 was the leading cause of death in India, as per the study. The age-standardised rate of deaths for both males and females was 156.8 per 100,000 population
Lifestyle-based checkups including diabetes, vitamin deficiency and hair fall, apart from comprehensive full-body checkups, are the most preferred by Indians
The global review of studies comparing pre-pandemic and during-pandemic data found that the complication of sight loss in people with diabetes also increased.
Drug, marketed under the brand name Lirafit, is priced at approximately Rs 100 for a standard daily dose of 1.2 mg
It is priced at around Rs 100 for a standard dose of 1.2mg (per day) and will lower the cost of therapy by approximately 70 per cent, the company claimed
Prevalence of diabetes no longer confined to just older demographics, Vitamin B12 deficiency may be a cause
Karwa Chauth is a delightful and sacred Hindu Celebration. In India, particularly in Northern parts of India, women fast from sunrise to moonrise for the well-being and long life of their spouses
Last week Tata AIG General Insurance launched a plan for this group, adding to the considerable number of plans already available
Under the agreement's terms, Biocon will be responsible for obtaining regulatory approvals for Liraglutide and will subsequently manage the manufacturing and distribution of the product within Canada
"Natural daylight is the strongest zeitgeber, or environmental cue, of the circadian clock, but most people are indoors during the day and so under constant artificial lighting," said Habets
The study was published in Proceedings of the National Academy of Science
The company's product is a therapeutic equivalent generic version of Kombiglyze XR tablets, it added
Akums Drugs and Pharmaceuticals on Thursday said it has received approval from the Drug Controller General of India (DCGI) for triple combination diabetes medication
An increased responsiveness of the human body to insulin during deep sleep, in turn, improving blood sugar control the next day, ma why lack of quality sleep is considered to increase risk of diabetes
If drug manufacturers are found flouting the ceiling, they will have to deposit the overcharged amount with the Centre
It is estimated that 101 million people in India - around 10 per cent of the country's population - are suffering from diabetes
Though costlier, they offer coverage for both type I and II diabetes, and to those with high levels of HbA1C
Novo and Lilly's experimental obesity pills helped people lose about 15% of body weight, similar to weight-loss shots on the market already, according to findings presented